Info
- Utilizzare la checkbox di selezione a fianco di ciascun documento per attivare le funzionalità di stampa, invio email, download nei formati disponibili del (i) record.
Advancing regulatory science for medical countermeasure development [[electronic resource] ] : workshop summary / / Theresa Wizemann, Bruce M. Altevogt, and Anne B. Claiborne, rapporteurs
| Advancing regulatory science for medical countermeasure development [[electronic resource] ] : workshop summary / / Theresa Wizemann, Bruce M. Altevogt, and Anne B. Claiborne, rapporteurs |
| Pubbl/distr/stampa | Washington, D.C., : National Academies Press, 2011 |
| Descrizione fisica | 1 online resource (150 pages) |
| Disciplina | 616.0250973 |
| Altri autori (Persone) |
WizemannTheresa M
AltevogtBruce M ClaiborneAnne B |
| Soggetto topico |
Emergency management - United States - Evaluation
Disaster medicine - United States - Evaluation Weapons of mass destruction - Health aspects Chemical agents (Munitions) |
| Soggetto genere / forma | Electronic books. |
| ISBN |
1-283-25354-2
9786613253545 0-309-21491-2 |
| Formato | Materiale a stampa  |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto | ""Front Matter""; ""Reviewers""; ""Contents""; ""Tables, Figures, and Boxes""; ""Acronyms""; ""1 Introduction""; ""2 MCM Enterprise and Stakeholder Perspectives""; ""3 Cutting-Edge Efforts to Advance MCM Regulatory Science""; ""4 MCM Regulatory Science Needs for At-Risk Populations""; ""5 Crosscutting Themes and Future Directions""; ""6 Closing Remarks""; ""References""; ""Appendix A: Workshop Agenda""; ""Appendix B: Participant Biographies"" |
| Record Nr. | UNINA-9910457701403321 |
| Washington, D.C., : National Academies Press, 2011 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Advancing regulatory science for medical countermeasure development [[electronic resource] ] : workshop summary / / Theresa Wizemann, Bruce M. Altevogt, and Anne B. Claiborne, rapporteurs
| Advancing regulatory science for medical countermeasure development [[electronic resource] ] : workshop summary / / Theresa Wizemann, Bruce M. Altevogt, and Anne B. Claiborne, rapporteurs |
| Pubbl/distr/stampa | Washington, D.C., : National Academies Press, 2011 |
| Descrizione fisica | 1 online resource (150 pages) |
| Disciplina | 616.0250973 |
| Altri autori (Persone) |
WizemannTheresa M
AltevogtBruce M ClaiborneAnne B |
| Soggetto topico |
Emergency management - United States - Evaluation
Disaster medicine - United States - Evaluation Weapons of mass destruction - Health aspects Chemical agents (Munitions) |
| ISBN |
0-309-21493-9
1-283-25354-2 9786613253545 0-309-21491-2 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto | ""Front Matter""; ""Reviewers""; ""Contents""; ""Tables, Figures, and Boxes""; ""Acronyms""; ""1 Introduction""; ""2 MCM Enterprise and Stakeholder Perspectives""; ""3 Cutting-Edge Efforts to Advance MCM Regulatory Science""; ""4 MCM Regulatory Science Needs for At-Risk Populations""; ""5 Crosscutting Themes and Future Directions""; ""6 Closing Remarks""; ""References""; ""Appendix A: Workshop Agenda""; ""Appendix B: Participant Biographies"" |
| Record Nr. | UNINA-9910781607803321 |
| Washington, D.C., : National Academies Press, 2011 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Advancing regulatory science for medical countermeasure development : workshop summary / / Theresa Wizemann, Bruce M. Altevogt, and Anne B. Claiborne, rapporteurs
| Advancing regulatory science for medical countermeasure development : workshop summary / / Theresa Wizemann, Bruce M. Altevogt, and Anne B. Claiborne, rapporteurs |
| Edizione | [1st ed.] |
| Pubbl/distr/stampa | Washington, D.C., : National Academies Press, 2011 |
| Descrizione fisica | 1 online resource (150 pages) |
| Disciplina | 616.0250973 |
| Altri autori (Persone) |
WizemannTheresa M
AltevogtBruce M ClaiborneAnne B |
| Soggetto topico |
Emergency management - United States - Evaluation
Disaster medicine - United States - Evaluation Weapons of mass destruction - Health aspects Chemical agents (Munitions) |
| ISBN |
0-309-21493-9
1-283-25354-2 9786613253545 0-309-21491-2 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto | ""Front Matter""; ""Reviewers""; ""Contents""; ""Tables, Figures, and Boxes""; ""Acronyms""; ""1 Introduction""; ""2 MCM Enterprise and Stakeholder Perspectives""; ""3 Cutting-Edge Efforts to Advance MCM Regulatory Science""; ""4 MCM Regulatory Science Needs for At-Risk Populations""; ""5 Crosscutting Themes and Future Directions""; ""6 Closing Remarks""; ""References""; ""Appendix A: Workshop Agenda""; ""Appendix B: Participant Biographies"" |
| Record Nr. | UNINA-9910810514303321 |
| Washington, D.C., : National Academies Press, 2011 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Building a national framework for the establishment of regulatory science for drug development [[electronic resource] ] : workshop summary / / Institute of Medicine of the National Academies ; Yeonwoo Lebovitz, Rebecca A. English, and Anne B. Claiborne, rapporteurs
| Building a national framework for the establishment of regulatory science for drug development [[electronic resource] ] : workshop summary / / Institute of Medicine of the National Academies ; Yeonwoo Lebovitz, Rebecca A. English, and Anne B. Claiborne, rapporteurs |
| Pubbl/distr/stampa | Washington, D.C., : National Academies Press, 2011 |
| Descrizione fisica | 1 online resource (95 p.) |
| Disciplina | 615.1 |
| Altri autori (Persone) |
LebovitzYeonwoo
EnglishRebecca A ClaiborneAnne B |
| Soggetto topico |
Pharmaceutical policy - United States
Drug development - Government policy - United States Pharmaceutical industry - Government policy - United States |
| Soggetto genere / forma | Electronic books. |
| ISBN |
1-283-01910-8
9786613019103 0-309-15890-7 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto | ""Front Matter""; ""Reviewers""; ""Contents""; ""Figures and Boxes""; ""Acronyms""; ""Preface""; ""1 Introduction""; ""2 Defining Regulatory Science""; ""3 The Urgent Need for Regulatory Science""; ""4 Barriers to Enhanced Regulatory Science""; ""5 Potential Models for Building a Regulatory Science Infrastructure""; ""6 Challenges in Engaging the Public Policy Community""; ""7 Envisioning Successful Regulatory Science at FDA""; ""8 Considering Next Steps""; ""References""; ""Appendix A: Agenda""; ""Appendix B: Participant Biographies"" |
| Record Nr. | UNINA-9910457137103321 |
| Washington, D.C., : National Academies Press, 2011 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Building a national framework for the establishment of regulatory science for drug development [[electronic resource] ] : workshop summary / / Institute of Medicine of the National Academies ; Yeonwoo Lebovitz, Rebecca A. English, and Anne B. Claiborne, rapporteurs
| Building a national framework for the establishment of regulatory science for drug development [[electronic resource] ] : workshop summary / / Institute of Medicine of the National Academies ; Yeonwoo Lebovitz, Rebecca A. English, and Anne B. Claiborne, rapporteurs |
| Pubbl/distr/stampa | Washington, D.C., : National Academies Press, 2011 |
| Descrizione fisica | 1 online resource (95 p.) |
| Disciplina | 615.1 |
| Altri autori (Persone) |
LebovitzYeonwoo
EnglishRebecca A ClaiborneAnne B |
| Soggetto topico |
Pharmaceutical policy - United States
Drug development - Government policy - United States Pharmaceutical industry - Government policy - United States |
| ISBN |
0-309-20959-5
1-283-01910-8 9786613019103 0-309-15890-7 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto | ""Front Matter""; ""Reviewers""; ""Contents""; ""Figures and Boxes""; ""Acronyms""; ""Preface""; ""1 Introduction""; ""2 Defining Regulatory Science""; ""3 The Urgent Need for Regulatory Science""; ""4 Barriers to Enhanced Regulatory Science""; ""5 Potential Models for Building a Regulatory Science Infrastructure""; ""6 Challenges in Engaging the Public Policy Community""; ""7 Envisioning Successful Regulatory Science at FDA""; ""8 Considering Next Steps""; ""References""; ""Appendix A: Agenda""; ""Appendix B: Participant Biographies"" |
| Record Nr. | UNINA-9910781299503321 |
| Washington, D.C., : National Academies Press, 2011 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Building a national framework for the establishment of regulatory science for drug development : workshop summary / / Institute of Medicine of the National Academies ; Yeonwoo Lebovitz, Rebecca A. English, and Anne B. Claiborne, rapporteurs
| Building a national framework for the establishment of regulatory science for drug development : workshop summary / / Institute of Medicine of the National Academies ; Yeonwoo Lebovitz, Rebecca A. English, and Anne B. Claiborne, rapporteurs |
| Edizione | [First edition.] |
| Pubbl/distr/stampa | Washington, D.C. : , : National Academies Press, , 2011 |
| Descrizione fisica | 1 online resource (95 pages) |
| Disciplina | 615.1 |
| Altri autori (Persone) |
LebovitzYeonwoo
EnglishRebecca A ClaiborneAnne B |
| Soggetto topico |
Pharmaceutical policy - United States
Drug development - Government policy - United States Pharmaceutical industry - Government policy - United States |
| ISBN |
0-309-20959-5
1-283-01910-8 9786613019103 0-309-15890-7 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto | ""Front Matter""; ""Reviewers""; ""Contents""; ""Figures and Boxes""; ""Acronyms""; ""Preface""; ""1 Introduction""; ""2 Defining Regulatory Science""; ""3 The Urgent Need for Regulatory Science""; ""4 Barriers to Enhanced Regulatory Science""; ""5 Potential Models for Building a Regulatory Science Infrastructure""; ""6 Challenges in Engaging the Public Policy Community""; ""7 Envisioning Successful Regulatory Science at FDA""; ""8 Considering Next Steps""; ""References""; ""Appendix A: Agenda""; ""Appendix B: Participant Biographies"" |
| Record Nr. | UNINA-9910828319503321 |
| Washington, D.C. : , : National Academies Press, , 2011 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
The emerging threat of drug-resistant tuberculosis in southern Africa [[electronic resource] ] : global and local challenges and solution : summary of a joint workshop / / by the Institute of Medicine and the Academy of Science of South Africa ; Steve Olson, Yeonwoo Lebovitz, and Anne Claiborne, rapporteurs; Forum on Drug Discovery, Development, and Translation, Board of Medicine, Institute of Medicine of the National Academies, and Academy of Science of South Africa
| The emerging threat of drug-resistant tuberculosis in southern Africa [[electronic resource] ] : global and local challenges and solution : summary of a joint workshop / / by the Institute of Medicine and the Academy of Science of South Africa ; Steve Olson, Yeonwoo Lebovitz, and Anne Claiborne, rapporteurs; Forum on Drug Discovery, Development, and Translation, Board of Medicine, Institute of Medicine of the National Academies, and Academy of Science of South Africa |
| Pubbl/distr/stampa | Washington, D.C., : National Academies Press, c2011 |
| Descrizione fisica | 1 online resource (146 p.) |
| Altri autori (Persone) |
ClaiborneAnne B
LebovitzYeonwoo OlsonSteve <1956-> |
| Soggetto topico |
Multidrug-resistant tuberculosis - Prevention - South Africa
Tuberculosis - South Africa Drug resistance |
| Soggetto genere / forma | Electronic books. |
| ISBN |
1-283-08154-7
9786613081544 0-309-16025-1 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Record Nr. | UNINA-9910456993703321 |
| Washington, D.C., : National Academies Press, c2011 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
The emerging threat of drug-resistant tuberculosis in southern Africa [[electronic resource] ] : global and local challenges and solution : summary of a joint workshop / / by the Institute of Medicine and the Academy of Science of South Africa ; Steve Olson, Yeonwoo Lebovitz, and Anne Claiborne, rapporteurs; Forum on Drug Discovery, Development, and Translation, Board of Medicine, Institute of Medicine of the National Academies, and Academy of Science of South Africa
| The emerging threat of drug-resistant tuberculosis in southern Africa [[electronic resource] ] : global and local challenges and solution : summary of a joint workshop / / by the Institute of Medicine and the Academy of Science of South Africa ; Steve Olson, Yeonwoo Lebovitz, and Anne Claiborne, rapporteurs; Forum on Drug Discovery, Development, and Translation, Board of Medicine, Institute of Medicine of the National Academies, and Academy of Science of South Africa |
| Pubbl/distr/stampa | Washington, D.C., : National Academies Press, c2011 |
| Descrizione fisica | 1 online resource (146 p.) |
| Altri autori (Persone) |
ClaiborneAnne B
LebovitzYeonwoo OlsonSteve <1956-> |
| Soggetto topico |
Multidrug-resistant tuberculosis - Prevention - South Africa
Tuberculosis - South Africa Drug resistance |
| ISBN |
0-309-21160-3
1-283-08154-7 9786613081544 0-309-16025-1 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto | Introduction -- The incidence of drug-resistant TB in South Africa -- Surveillance and tracking of drug-resistant TB -- Transmission and infection control -- Diganosis of drug-resistant TB -- Treatment of drug-resistant TB -- Drug-resistant TB in children -- Convergence of science and policy to create a blueprint for action. |
| Record Nr. | UNINA-9910781390303321 |
| Washington, D.C., : National Academies Press, c2011 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
The emerging threat of drug-resistant tuberculosis in southern Africa : global and local challenges and solution : summary of a joint workshop / / by the Institute of Medicine and the Academy of Science of South Africa ; Steve Olson, Yeonwoo Lebovitz, and Anne Claiborne, rapporteurs; Forum on Drug Discovery, Development, and Translation, Board of Medicine, Institute of Medicine of the National Academies, and Academy of Science of South Africa
| The emerging threat of drug-resistant tuberculosis in southern Africa : global and local challenges and solution : summary of a joint workshop / / by the Institute of Medicine and the Academy of Science of South Africa ; Steve Olson, Yeonwoo Lebovitz, and Anne Claiborne, rapporteurs; Forum on Drug Discovery, Development, and Translation, Board of Medicine, Institute of Medicine of the National Academies, and Academy of Science of South Africa |
| Edizione | [1st ed.] |
| Pubbl/distr/stampa | Washington, D.C., : National Academies Press, c2011 |
| Descrizione fisica | 1 online resource (146 p.) |
| Altri autori (Persone) |
ClaiborneAnne B
LebovitzYeonwoo OlsonSteve <1956-> |
| Soggetto topico |
Multidrug-resistant tuberculosis - Prevention - South Africa
Tuberculosis - South Africa Drug resistance |
| ISBN |
0-309-21160-3
1-283-08154-7 9786613081544 0-309-16025-1 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto | Introduction -- The incidence of drug-resistant TB in South Africa -- Surveillance and tracking of drug-resistant TB -- Transmission and infection control -- Diganosis of drug-resistant TB -- Treatment of drug-resistant TB -- Drug-resistant TB in children -- Convergence of science and policy to create a blueprint for action. |
| Record Nr. | UNINA-9910813657603321 |
| Washington, D.C., : National Academies Press, c2011 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Envisioning a transformed clinical trials enterprise in the United States [[electronic resource] ] : establishing an agenda for 2020: workshop summary / / Neil Weisfeld, Rebecca A. English, and Anne B. Claiborne, rapporteurs; Forum on Drug Discovery, Development, and Translation; Board on Health Sciences Policy
| Envisioning a transformed clinical trials enterprise in the United States [[electronic resource] ] : establishing an agenda for 2020: workshop summary / / Neil Weisfeld, Rebecca A. English, and Anne B. Claiborne, rapporteurs; Forum on Drug Discovery, Development, and Translation; Board on Health Sciences Policy |
| Pubbl/distr/stampa | Washington, : National Academies Press, 2012 |
| Descrizione fisica | 1 online resource (232 p.) |
| Disciplina | 615.50724 |
| Altri autori (Persone) |
WeisfeldNeil E
EnglishRebecca A ClaiborneAnne B |
| Soggetto topico |
Clinical trials - United States
Clinical medicine - Research - United States |
| Soggetto genere / forma | Electronic books. |
| ISBN |
1-283-63636-0
0-309-25316-0 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto |
""Front Matter""; ""Reviewers""; ""Contents""; ""Tables, Figures, and Boxes""; ""Acronyms""; ""1 Introduction""; ""2 Integrating Community Practice and Clinical Trials""; ""3 Improving Public Participation in Clinical Trials""; ""4 Creating a New Business Model for Clinical Trials""; ""5 Building an Infrastructure to Support Clinical Trials""; ""6 Suggesting an Agenda for Transforming Elements of the Clinical Trials Enterprise""; ""References""; ""Appendix A: Workshop Agenda""; ""Appendix B: Participant Biographies""; ""Appendix C: Registered Workshop Attendees""
""Appendix D: Discussion Paper: The Clinical Trials Enterprise in the United States: A Call for Disruptive Innovation""""Appendix E: Discussion Paper: Developing a Robust Clinical Trials Workforce""; ""Appendix F: Discussion Paper: Transforming the Economics of Clinical Trials""; ""Appendix G: Discussion Paper: Developing a Clinical Trials Infrastructure""; ""Appendix H: Discussion Paper: Canadian Strategy on Patient-Oriented Research""; ""Appendix I: Discussion Paper: Health Research as a Public Good""; ""Appendix J: Discussion Paper: Novel Ways to Get Good Trial Data: The UK Experience"" ""Appendix K: IOM Staff Paper: Context and Glossary of Select Terms Associated with the Clinical Trials Enterprise"" |
| Record Nr. | UNINA-9910462082103321 |
| Washington, : National Academies Press, 2012 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
